|
|
|
Agenda: Day One
Monday, June 7, 2004
|
7:00 a.m. |
Registration Commences
|
8:00 a.m. |
Welcome and Introduction
John K. Iglehart
Founding Editor, Health Affairs
National Correspondent, New England Journal of Medicine
Washington, DC
(Colloquium Co chair)
|
8:15 a.m. |
Challenges Facing International Pharmaceutical Enterprises
Fred Hassan, MBA
Chairman and Chief Executive Officer, Schering-Plough Corporation
Past Chairman, Pharmaceutical Research & Manufacturers of America (PhRMA)
Kenilworth, NJ
|
8:45 a.m. |
What Will be the Market Differentiators for Pharmaceutical, Biotechnology and Device Companies of the Future?
John C. Lechleiter, Ph.D.
Executive Vice President, Pharmaceutical Operations
Eli Lilly and Company
Indianapolis, IN
|
9:15 a.m. |
Strategic Imperatives for the Pharmaceutical Enterprise of the Future
Rose Crane
Executive Vice President
Pharmaceuticals Group Strategic Marketing
Johnson and Johnson Pharmaceutical Services LLC
Raritan NJ
|
9:45 a.m. |
Building People Capability at Dell - Lessons for Pharma, Biotech and Device Enterprises
Peter Leddy
Vice President, Global HR Services
Dell Inc.
Round Rock, TX
Handout Material (Acrobat)
Handout Material (Microsoft Word)
|
10:15 a.m. |
Break
|
10:45 a.m. |
Introduction to Compliance Officer Roundtable
Brian Salsberg, JD
Associate Principal, Pharmaceutical and Medical Products Practice
McKinsey & Company
Florham Park, NJ
(Colloquium Co Chair)
Brenton L. Saunders, JD, MBA
Senior Vice President, Global Compliance and Business Practices
Schering-Plough Corporation
Past President, Health Care Compliance Association
Founder, International Association of Privacy Professionals
Kenilworth, NJ
(Colloquium Co Chair)
|
11:00 a.m. |
Building the Compliance Program of the Future and its Role in Strategic Business Strategy
|
|
The Role of a Company's Compliance Program in Enhancing the Reputation of the Enterprise
Lori Queisser
Vice President and Chief Compliance Officer
Eli Lilly and Company
Indianapolis, IN
|
|
The Role of a Company's Compliance Program in Implementing a Program of Enterprise Risk Management
Bert Weinstein, Esq.
Vice President, Corporate Compliance
Purdue Pharma
Stamford, CT
Presentation Material (Acrobat)
Presentation Material (Powerpoint)
|
|
Measuring the Effectiveness of a Company's Compliance Program
L. Stephan Vincze, Esq.
Ethics & Compliance Officer
TAP Pharmaceuticals
Lake Forest, IL
|
|
The Special Compliance Challenges of Biopharmaceutical Enterprises
Liz Lewis, Esq.
Associate General Counsel
Millennium Pharmaceuticals, Inc.
Cambridge, MA
|
|
The Special Compliance Challenges of Device Manufacturers
Link Bonforte
Vice President, Government Affairs
Policy and Compliance, ConvaTec
Skillman, NJ
|
|
The Compliance Program of the Future
Charles Brock
Vice President and Chief Ethics and Compliance Officer
Abbott Laboratories
Abbott Park, IL
Gary Giampetruzzi, Esq.
Senior Corporate Counsel
Pfizer Inc.
New York, NY
(Moderator)
|
12:30 p.m. |
Employer's Perspective on the Role of Pharma, Biotech and Device Sectors
Robert S. Galvin, MD, MBA
Director, Global Healthcare
General Electric Company
Founding Member, The Leap Frog Group
Vice Chair, Washington Business Group on Health
Fairfield, CT
Presentation Material (Acrobat)
Presentation Material (Powerpoint)
|
1:00 p.m. |
Networking Luncheon
|
|
2:00 p.m. - 6:00 p.m. |
COMPREHENSIVE COMPLIANCE, RISK MANAGEMENT AND BUSINESS STRATEGY TRACKS
(Choose One Track Only)
|
Track I A: Compliance Implications on the Future of Sales and Marketing and Medical Affairs Organizations
|
2:00 p.m. |
Medical Affairs - The Next S-Curve in Pharma
Michael Conway
Principal, Pharmaceutical and Medical Products Practice
McKinsey & Company, Inc.
Florham Park, NJ
(Co chair)
Presentation Material (Acrobat)
Presentation Material (Powerpoint)
David Quigley
Associate Principal, Pharmaceutical and Medical Products Practice
McKinsey & Company, Inc.
New York, NY
(Co chair)
|
2:15 p.m. |
Building the Medical Affairs Organization of the Future
Eric B. Grossman, MD, FACP
Senior Director, Hypertension, Heart Failure and Diabetes
Pfizer Global Pharmaceuticals
Pfizer Inc.
New York, NY
Presentation Material (Acrobat)
Presentation Material (Powerpoint)
Michael Kafrissen
Vice President for Clinical Affairs
Ortho-McNeil Pharmaceutical
a Johnson & Johnson Company
Raritan, NJ
Presentation Material (Acrobat)
Presentation Material (Powerpoint)
Francois Nader, MD, MBA
Senior Vice President
Medical Affairs North America
Aventis Pharmaceuticals
Bridgewater, NJ
Presentation Material (Acrobat)
Presentation Material (Powerpoint)
|
3:15 p.m. |
New Guidance and the Future of Industry-Supported CME
Mark Wanda, Esq.
Vice President, Legal Affairs
Sepracor Inc.
Marlborough, MA
|
4:00 p.m. |
Break
|
4:30 p.m. |
Designing the Sales Force of the Future: Getting It Right
Eric Aaronson, Esq.
Corporate Counsel, Pfizer Learning Center
Pfizer Inc.
Rye Brook, NY
Nancy S. Lurker
Chief Executive Officer and President
ImpactRx, Inc.
Mt. Laurel, NJ
Michele Pesanello
Partner, IBM Business Consulting Services
Florham Park, NJ
Charles T. Saldarini
Chief Executive Officer , PDI Inc.
Upper Saddle River, NJ
Presentation Material (Acrobat)
Presentation Material (Powerpoint)
Brian Riewerts
Senior Manager
Global Pharmaceutical Advisory Services Group
PricewaterhouseCoopers LLP
Baltimore, MD
(Moderator)
|
6:00 p.m. |
Adjournment and Opening Reception at Princeton Faculty Club
|
|
Track I B: Governance and Enterprise Risk Management
|
2:00 p.m. |
Introduction
Glenn P. Brady
Partner, PricewaterhouseCoopers
New York, NY
(Chair)
|
2:15 p.m. |
Risk Management: What Pharma, Biotech and Device Organizations Can Learn from Other Industries
Kevin Buehler
Principal and Co chair
North American Risk Management Practice
McKinsey & Company
New York, NY
|
2:45 p.m. |
ERM - Making it Happen: In-house Counsel's Role in Designing and Implementing ERM Programs
Rupert Bondy, Esq.
General Counsel, GlaxoSmithKline
Brentford, Middlesex, UK
Thomas Sabatino, Esq.
General Counsel
Schering-Plough Corporation
Kenilworth, NJ
Linda Willett, Esq.
Vice President and Deputy General Counsel
Bristol-Myers Squibb Company
New York, NY
Presentation Material (Acrobat)
Presentation Material (Powerpoint)
Glenn P. Brady
Partner, PricewaterhouseCoopers
New York, NY
(Moderator)
|
4:00 p.m. |
Adjournment and Transfer to Other Track
|
|
Track I C: Pharma/Device Regulators Roundtable and Law School for Pharmaceutical and Medical Device Manufacturer Executives
|
2:00 p.m. |
Introduction
Brenton L. Saunders, JD, MBA
Senior Vice President, Global Compliance and Business Practices
Schering-Plough Corporation
Past President, Health Care Compliance Association
Founder, International Association of Privacy Professionals
Kenilworth, NJ
(Chair)
|
2:15 p.m. |
Pharmaceutical, Biotech and Device Sector Regulator Roundtable
Thomas W. Abrams, RPh, MBA
Director, Division of Drug Marketing, Advertising & Communications
Food and Drug Administration
Rockville, MD
David J. Butler
Chief Operating Officer
Strategic Management Systems, Inc.
Former Deputy Associate Administrator
Operations and Resource Management
Health Care Financing Administration
Alexandria, VA
Virginia Gibson, Esq.
Assistant U.S. Attorney
Chief, Civil Division
Eastern District of Pennsylvania
Philadelphia, PA
Karen A. Morrissette, Esq.
Deputy Chief, Fraud Section, Criminal Division
United States Department of Justice
Washington, DC
|
3:45 p.m. |
Break
|
4:15 p.m. |
Law School for Pharmaceutical and Medical Device Manufacturer Executives
John Bentivoglio, Esq.
Partner, Arnold and Porter
Former Special Counsel for Healthcare Fraud and Chief Privacy Officer
United States Department of Justice
Washington, DC
Paul E. Kalb, MD, JD
Partner, Sidley Austin Brown & Wood
Washington, DC
Presentation Material (Acrobat)
Presentation Material (Powerpoint)
Brien T. O'Connor, Esq.
Partner, Ropes & Gray LLP
Former Chief of Public Corruption and Special Prosecutions
United States Attorney's Office
Boston, MA
Presentation Material (Acrobat)
Presentation Material (Powerpoint)
Edwin D. Rauzi, Esq.
Partner, Davis Wright Tremaine LLP
Seattle, WA
Presentation Material (Acrobat)
Presentation Material (Powerpoint)
John F. Sweeney, Esq.
Partner, Morgan and Finnegan
New York, NY
Presentation Material (Acrobat)
Presentation Material (Powerpoint)
|
6:00 p.m. |
Adjournment and Opening Reception at Princeton Faculty Club
|
|
